Billionaire investor and businessman Mark Cuban recently met with leaders at Penn Medicine, including University of Pennsylvania Health System CEO Kevin Mahoney (left) and Penn Medicine vice president ...
The US Food and Drug Administration (FDA) on Friday announced it will begin prioritizing abbreviated new drug applications (ANDAs) for generic submissions for which there is currently only one ...
Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results